BiotechTube
Home/Neuren Pharmaceuticals/Dianne Angus
DA

Dianne Angus

Non-Executive Director

Neuren Pharmaceuticals

Therapeutic Areas

Neurodevelopmental DisordersNeurodegenerative Disorders

Neuren Pharmaceuticals Pipeline

DrugIndicationPhase
DAYBUE® (trofinetide)Rett SyndromeApproved
NNZ-2591Phelan-McDermid SyndromePhase 2

Leadership Team at Neuren Pharmaceuticals

PD
Patrick Davies
Non-Executive Chair
JP
Jon Pilcher
Chief Executive Officer/Managing Director
View full Neuren Pharmaceuticals profile